ArticleVaccine2022
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 23 citations in OpenAlex.
- Understanding pneumococcal vaccine perceptions in seven countries: Findings from a cross-sectional survey.Human vaccines & immunotherapeutics · 2026Article
- Stakeholder readiness in the evolving adult vaccine market.iScience · 2025Article
- Perceptions and attitudes toward COVID-19 vaccination among health professional students in Australia: a qualitative study.Journal of public health policy · 2024Article
- A conceptual framework to model social determinants of COVID-19 vaccination uptake among underserved homeless populations.Vaccine: X · 2024Article
- Local stakeholder's viewpoint on Vlassov's contribution.European journal of public health · 2024Article
- COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention.BMC public health · 2024Article
- Priming congruence and COVID-19 vaccination intention: a mediation analysis.Health psychology report · 2024Article
- Article
- EU Member States' Institutional Twitter Campaigns on COVID-19 Vaccination: Analyses of Germany, Spain, France and Italy.Vaccines · 2023Article
- Comparison of SARS-CoV-2 Vaccination Skepticism, Reasons, and Concerns Between Mass Vaccination Centers and General Practices in Germany 2021.Patient preference and adherence · 2023Article
- Determinants of COVID-19 Vaccination Intention among Health Care Workers in France: A Qualitative Study.Vaccines · 2022Article
- How to overcome hesitancy for COVID-19 and other vaccines.The Journal of family practice · 2022Article
- COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France.Vaccine · 2022Article
- UK ethnic minority healthcare workers' perspectives on COVID-19 vaccine hesitancy in the UK ethnic minority community: A qualitative study.Frontiers in psychology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.